Artificial Intelligence–Driven Product Lifecycle Optimization in Biopharmaceutical Manufacturing

Artificial Intelligence–Driven Product Lifecycle Optimization in Biopharmaceutical Manufacturing

Mahendra Deshmukh1   Dr Reetha Dinesh2

1IIBM Scholar, EUROPEAN INSTITUTE OF APPLIED SCIENCE AND MANAGEMENT (EIASM)

   2Faculty & Thesis Guide, IIBM

 

Abstract

Artificial Intelligence (AI) is revolutionizing the biopharmaceutical industry by enabling data-driven decision-making, process automation, and predictive optimization across the product lifecycle. This research explores how AI-driven Product Lifecycle Management (PLM) transforms biopharmaceutical manufacturing by enhancing efficiency, compliance, and sustainability from R&D to commercialization. The study integrates theoretical frameworks with industry case analyses to demonstrate how machine learning (ML), digital twins, and big data analytics optimize formulation, scale-up, quality control, and market surveillance. It also identifies regulatory and ethical challenges associated with AI deployment in regulated environments. The paper concludes with a proposed AI-Integrated Biopharma Lifecycle Optimization Model, offering a roadmap for integrating AI, Quality by Design (QbD), and Good Manufacturing Practices (GMP) into a unified, future-ready PLM framework.

Keywords: Artificial Intelligence, Product Lifecycle Management, Biopharmaceutical Manufacturing, Quality by Design, Digital Twin, Predictive Analytics, Regulatory Compliance.

DOI link – https://doi.org/10.69758/GIMRJ/2510S01V13P005

Download